JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

Inicio・Lista de Acciones・Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc

Cerrado

SectorSanidad

24.3 -1.14

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

24.21

Máximo

24.59

Métricas clave
By Trading Economics
Ingresos	675K 53M
Ventas	1.8M 148M
P/B Media del Sector	14.029 90.422
Margen de beneficios	35.57
Empleados	181
EBITDA	1.7M 80M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+38.32% upside

Dividendos
By Dow Jones
Próximas Ganancias	25 feb 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	325M 2.9B
Apertura anterior	25.44
Cierre anterior	24.3

Noticias sobre sentimiento de mercado

By Acuity

19%

81%

30 / 352 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

N/A / 24.28 Soporte y Resistencia

Catalyst Pharmaceuticals Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

30 ene 2026, 20:14 UTC

Adquisiciones, fusiones, absorciones

Reddy Ice to Buy Arctic Glacier, DOJ Requires Certain Divestitures

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia, OpenAI in Talks to Revise Nature of Broader Partnership, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia CEO Jensen Huang Has Privately Told Colleagues That Deal Is Non-Binding, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia's Huang Has Privately Criticized OpenAI's Business Strategy, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

OpenAI, Nvidia Deal Talks Stalled in Recent Months, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia's Huang Expressed Concerns Over Competition OpenAI Faces From Anthropic, Google, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia Weighing Equity Investment of Tens of Billions of Dollars Into OpenAI, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Negotiations Over $100B OpenAI, Nvidia Deal Stall, Sources Say -- WSJ

30 ene 2026, 23:41 UTC

Charlas de Mercado

Deckers Outdoor Seen as Undervalued -- Market Talk

30 ene 2026, 23:12 UTC

Adquisiciones, fusiones, absorciones

Supreme Court of British Columbia Approves Fortescue Purchase of Alta Copper

30 ene 2026, 22:20 UTC

Ganancias

Verizon Posts Strong Subscriber Gains Under New CEO -- WSJ

30 ene 2026, 22:10 UTC

Charlas de Mercado

Disney CEO's Exit Plan Marks Abrupt End to Messy Succession -- Market Talk

30 ene 2026, 21:50 UTC

Charlas de Mercado

Ganancias

Tech, Media & Telecom Roundup: Market Talk

30 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

30 ene 2026, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

30 ene 2026, 21:42 UTC

Ganancias

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30 ene 2026, 21:36 UTC

Ganancias

GE Aerospace and GE Vernova Issue Their Annual Reports. They Contain Messages for Investors. -- Barrons.com

30 ene 2026, 21:33 UTC

Ganancias

Tesla Stock Rebounds From Earnings Dip. SpaceX Is Helping. -- Barrons.com

30 ene 2026, 20:42 UTC

Ganancias

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30 ene 2026, 20:37 UTC

Adquisiciones, fusiones, absorciones

Why a Ruling Over CK Hutchison's Panama Canal Ports Matters -- and What's Next -- WSJ

30 ene 2026, 20:20 UTC

Charlas de Mercado

Oil Posts Weekly Gains on U.S.-Iran Tensions -- Market Talk

30 ene 2026, 20:13 UTC

Charlas de Mercado

U.S. Natural Gas Futures Rise on Weather-Driven Demand -- Market Talk

30 ene 2026, 19:52 UTC

Ganancias

Visa and Amex Results Point to a Strong Holiday Season for Retailers -- Barrons.com

30 ene 2026, 19:29 UTC

Charlas de Mercado

Ganancias

KLA Guidance Only 'Tepid' as Memory Rally Favors Peers -- Market Talk

30 ene 2026, 19:09 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

30 ene 2026, 19:09 UTC

Charlas de Mercado

Next Canadian Inflation Release Pushed Back a Day to Not Clash With Holiday -- Market Talk

30 ene 2026, 19:07 UTC

Charlas de Mercado

Canada Performing Well Below Economic Potential -- Market Talk

30 ene 2026, 18:46 UTC

Ganancias

'All Boats Are Rising' in Data and Memory, Says Western Digital's CFO. Just Look at the Stocks. -- Barrons.com

30 ene 2026, 18:34 UTC

Ganancias

Exxon, Chevron Post Slimmest Annual Profits Since 2021 -- 2nd Update

Comparación entre iguales

Cambio de precio

Catalyst Pharmaceuticals Inc previsión

Precio Objetivo

By TipRanks

38.32% repunte

Estimación a 12 Meses

Media 34 USD 38.32%

Máximo 35 USD

Mínimo 33 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Catalyst Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Catalyst Pharmaceuticals Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

N/A / 24.28Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Sentimiento

By Acuity

30 / 352 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.